Form 8-K AQUINOX PHARMACEUTICALS, For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Leerink Maintains Aquinox Pharma (AQXP) at 'Outperform'; End-of-Phase 2 FDA Meeting is Next Catalyst
November 10, 2015 2:18 PM ESTLeerink affirms Aquinox Pharma (Nasdaq: AQXP) with an Outperform rating and $26 price target following the company's Q3 results and update... More
Aquinox Pharma (AQXP) Posts Narrower-than-Expected Q3 Loss
November 10, 2015 9:20 AM ESTAquinox Pharma (NASDAQ: AQXP) reported Q3 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45).
With positive results from the LEADERSHIP trial, we are advancing towards pivotal trials in bladder pain syndrome/interstitial cystitis (BPS/IC) with AQX-1125, said Mr. David Main, President and... More
